HAVANA, Cuba, Dec 23 (ACN) A nanobiomedical tool for the control of the COVID-19 pandemic is the first of four works competing for the National Awards of the Cuban Academy of Sciences of Sciences for scientific research results in 2021.
SARS-COV 2: High Resolution Microscopy is the title of this innovative product of the Center for Advanced Studies of Cuba (CEA), presented at a workshop for the defense of its scientific-technical results of the year with a view to its approval by the Technical Advisory Board of the Agency of Nuclear Energy and Advanced Technologies (AENTA).
Brian Mondeja Rodríguez, Ph.D., its lead author, gave details of its origins during a two-day conference at Hotel Nacional de Cuba, where he recalled the recording of the first images of SARS-CoV-2 in clinical samples using high-resolution microscopy.
“These profiles led us to study individuals with persistent infection to check for viral excretion in post-symptomatic or asymptomatic patients and to evaluate in vitro procedures to establish their effectiveness and the inhibition of viral replication in cell cultures,” he explained. “It also made it possible to clean and sterilize by irradiation the plates of the ribonucleic acid (RNA) extraction system, in order to reuse them in our molecular biology laboratories and thus save hard currency.”
Manuel Fernandez Rondon, director of Science and Innovation at AENTA, told ACN that this and the other three technologies they submitted to the jury of the ACC national awards—namely, the Scientific, Technological and Research Observatory of Cuba (Institute of Scientific and Technological Information, IDICT); Image Processing (Institute of Cybernetics, Mathematics and Physics, ICIMAF); and Seismological Studies of Cuba (National Center for Seismological Research, CENAIS)—have already been approved by its Advisory Council of Science and Technology and are only presented for public knowledge.
Fernández Rondón pointed out that these are in general relevant results, as evidenced by the scope of the first Cuban product of nanoscience and nanotechnology to produce RNA extraction reagents, hitherto imported, before the PCR test.
He emphasized that once a jury of experts evaluates these scientific-technical results and services of the year, 29 of them will be submitted to the approval of AENTA's Technical Advisory Council on December 28.
Nos reservamos el derecho de no publicar los comentario que incumplan con las normas de este sitio